Valentina Vultaggio-Poma

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR

Alessandra Mangolini, Manuela Ferracin, Maria Vittoria Zanzi et al. · Biomarker Research · 2015 · 94 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine

Paola Chiozzi, Alba Clara Sarti, Juana María Sanz et al. · Scientific Reports · 2019 · 69 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells

Francesco Di Virgilio, Lin‐Hua Jiang, Sébastien Roger et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2019 · 58 citations

Medicine, Biochemistry, Pharmacology +14